Mark Packer is internationally recognized as a leader in ophthalmology, the author of original research establishing innovative techniques and groundbreaking technologies. He is widely respected for his medical, clinical and regulatory expertise by companies in the medical device and pharmaceutical space, including Abbott Medical Optics, Advanced Vision Science, Aerie Pharmaceuticals, Alcon Laboratories, Allergan, Bausch & Lomb, Cassini Technologies, General Electric Health Care, International Biomedical Devices, Johnson & Johnson, Lensar, Oculeve, Promedica International, Rayner, Refocus Group, SOLX, STAAR Surgical, Transcend Medical, True Vision Systems, VisionCare Ophthalmic Technologies and WaveTec Vision Systems. He has served as Principal Investigator or Medical Monitor in over sixty clinical trial protocols leading to FDA clearances and approvals. Dr. Packer’s peer-­reviewed publications include “Evaluation of the Aspheric Tecnis Multifocal Intraocular Lens” in American Journal of Ophthalmology, “Effect of Intraoperative Aberrometry on the Rate of Postoperative Enhancement” in Journal of Cataract and Refractive Surgery, and “Office-Based Cataract Surgery” in Ophthalmology. He has edited textbooks on cataract and refractive lens surgery, written hundreds of book chapters and medical articles, and served as editor for the annual Cataract and IOL issue of Current Opinion in Ophthalmology. He has served on the Editorial Board of the Journal of Refractive Surgery. Elected to membership in the prestigious International Intra ocular Implant Club in 2005, he has delivered hundreds of presentations at scientific meetings around the world and demonstrated cataract surgery before a live audience at conferences throughout Europe, Asia and the Americas.Mark Packer’s career demonstrates his dedication to improving care and enhancing outcomes through innovation. His goal remains increased safety and optimal results for all patients.